1 Introduction
1.1 What Is This Report About?
1.2 Metabolic Disorders Market Segmentation
1.3 Definitions of Markets Covered in the Report
2 Metabolic Disorders Market, Canada
2.1 Metabolic Disorders Market, Canada, Revenue ($m), 2024-2036
2.1.1 Cholesterol Tests Market, Canada, Revenue ($m), by Segment, 2024-2036
2.1.2 Diabetes Assays Market, Canada, Revenue ($m), by Segment, 2024-2036
2.2 Metabolic Disorders Market, Canada, Volume (Units), 2024-2036
2.2.1 Cholesterol Tests Market, Canada, Volume (Units), by Segment, 2024-2036
2.2.2 Diabetes Assays Market, Canada, Volume (Units), by Segment, 2024-2036
2.3 Metabolic Disorders Market, Canada, Average Price ($), 2024-2036
2.4 Metabolic Disorders Market, Canada, Company Share by Revenue ($m), 2025
3 Metabolic Disorders Market Pipeline Products
3.1 Metabolic Disorders Market Pipeline Products
3.2 Metabolic Disorders - Pipeline Products by Stage of Development
3.3 Metabolic Disorders - Pipeline Products by Segment
3.4 Metabolic Disorders - Pipeline Products by Territory
3.5 Metabolic Disorders - Pipeline Products by Regulatory Path
3.6 Metabolic Disorders - Pipeline Products by Estimated Approval Date
4 Overview of Key Companies in Canada, Metabolic Disorders Market
4.1 Roche Diagnostics International Ltd
4.1.1 Company Overview
4.2 Siemens Healthineers AG
4.2.1 Company Overview
4.3 Abbott Laboratories
4.3.1 Company Overview
4.4 Ortho Clinical Diagnostics Holdings Ltd (Inactive)
4.4.1 Company Overview
4.5 Beckman Coulter Inc
4.5.1 Company Overview
4.6 Bio-Rad Laboratories Inc
4.6.1 Company Overview
5 Recent Developments
5.1 Corporate Communications
5.1.1 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research
5.2 Other Significant Developments
5.2.1 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research
5.2.2 Oct 22, 2025: Visionary Holdings Launches Joint Venture in Toronto for Stem Cell Therapy Commercialization
5.2.3 Sep 23, 2025: Microbix Assisting EMQN With Second Genetic-Test EQA Program
5.2.4 Sep 22, 2025: Emergent BioSolutions Secures $29 Million in Product Orders from International Government Partner
5.3 Strategy And Business Planning
5.3.1 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research
5.3.2 Oct 22, 2025: Visionary Holdings Launches Joint Venture in Toronto for Stem Cell Therapy Commercialization
5.3.3 Sep 22, 2025: Emergent BioSolutions Secures $29 Million in Product Orders from International Government Partner
6 Appendix
6.1 Research Methodology
6.1.1 Coverage
6.1.2 Secondary Research
6.1.3 Primary Research
6.1.4 Market Modeling and Forecasting
6.1.5 Company Share Analysis
6.1.6 Benchmarking
6.2 the Analyst Consulting
6.3 Contact Us
6.4 Disclaimer
List of Tables
Table 1: Metabolic Disorders Market, Canada, Revenue ($m), USD Constant, 2024-2036
Table 2: Cholesterol Tests Market, Canada, Revenue ($m), USD Constant, 2024-2036
Table 3: Diabetes Assays Market, Canada, Revenue ($m), USD Constant, 2024-2036
Table 4: Metabolic Disorders Market, Canada, Volume (Units), 2024-2036
Table 5: Cholesterol Tests Market, Canada, Volume (Units), 2024-2036
Table 6: Diabetes Assays Market, Canada, Volume (Units), 2024-2036
Table 7: Metabolic Disorders Market, Canada, Average Price ($), 2024-2036
Table 8: Metabolic Disorders Market, Canada, Company Share by Revenue ($m), USD Constant, 2025
Table 9: Metabolic Disorders Market Pipeline Products
Table 10: Metabolic Disorders - Pipeline Products by Stage of Development
Table 11: Metabolic Disorders Companies - Pipeline Products by Stage of Development
Table 12: Metabolic Disorders - Pipeline Products by Segment
Table 13: Metabolic Disorders - Pipeline Products by Territory
Table 14: Metabolic Disorders - Pipeline Products by Regulatory Path
Table 15: Metabolic Disorders - Pipeline Products by Estimated Approval Date
Table 16: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country
List of Figures
Figure 1: Metabolic Disorders Market, Canada, Revenue ($m), USD Constant, 2024-2036
Figure 2: Cholesterol Tests Market, Canada, Revenue ($m), USD Constant, 2024-2036
Figure 3: Diabetes Assays Market, Canada, Revenue ($m), USD Constant, 2024-2036
Figure 4: Metabolic Disorders Market, Canada, Volume (Units), 2024-2036
Figure 5: Cholesterol Tests Market, Canada, Volume (Units), 2024-2036
Figure 6: Diabetes Assays Market, Canada, Volume (Units), 2024-2036
Figure 7: Metabolic Disorders Market, Canada, Company Share (%), 2025
Figure 8: Metabolic Disorders - Pipeline Products by Stage of Development
Figure 9: Metabolic Disorders - Pipeline Products by Segment
Figure 10: Metabolic Disorders - Pipeline Products by Territory
Figure 11: Metabolic Disorders - Pipeline Products by Regulatory Path
Figure 12: Metabolic Disorders - Pipeline Products by Estimated Approval Date
